敗血症治療薬世界市場の発展状況と動向 2024-2030
英文タイトル: Global Sepsis Therapeutics Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
サンプルお申込み
お問い合わせ
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は敗血症治療薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは敗血症治療薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の敗血症治療薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは敗血症治療薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に敗血症治療薬市場を分類しています。本研究に含まれる主な企業は:Agennix、AstraZeneca、Atox Bio、CytoGenix、Eli Lilly、Endacea、NexBio、Medinox
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Aminoglycosides
Colony Stimulating Factors
Second Generation Cephalosporins
Third Generation Cephalosporins
Glycopeptide Antibiotics
Inhaled Intifectives
Others
用途別の市場セグメント:
Hospitals
Clinics
Other
本レポートの詳細内容
世界の敗血症治療薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、敗血症治療薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の敗血症治療薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の敗血症治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、敗血症治療薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
敗血症治療薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:敗血症治療薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:敗血症治療薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章敗血症治療薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:敗血症治療薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:敗血症治療薬の主要企業の概要を提供し、製品の説明と仕様、敗血症治療薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not. Market Analysis and Insights: Global Sepsis Therapeutics Market The global Sepsis Therapeutics market is projected to grow from US$ 3611.2 million in 2024 to US$ 5329 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Report Covers: This report presents an overview of global market for Sepsis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Sepsis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sepsis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Sepsis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Sepsis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Sepsis Therapeutics revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Agennix, AstraZeneca, Atox Bio, CytoGenix, Eli Lilly, Endacea, NexBio and Medinox, etc. Market Segmentation By Company Agennix AstraZeneca Atox Bio CytoGenix Eli Lilly Endacea NexBio Medinox Segment by Type Aminoglycosides Colony Stimulating Factors Second Generation Cephalosporins Third Generation Cephalosporins Glycopeptide Antibiotics Inhaled Intifectives Others Segment by Application Hospitals Clinics Other By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Sepsis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Sepsis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sepsis Therapeutics revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Aminoglycosides
1.2.3 Colony Stimulating Factors
1.2.4 Second Generation Cephalosporins
1.2.5 Third Generation Cephalosporins
1.2.6 Glycopeptide Antibiotics
1.2.7 Inhaled Intifectives
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sepsis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Therapeutics Market Perspective (2019-2030)
2.2 Global Sepsis Therapeutics Growth Trends by Region
2.2.1 Sepsis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sepsis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Sepsis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Sepsis Therapeutics Market Dynamics
2.3.1 Sepsis Therapeutics Industry Trends
2.3.2 Sepsis Therapeutics Market Drivers
2.3.3 Sepsis Therapeutics Market Challenges
2.3.4 Sepsis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sepsis Therapeutics by Players
3.1.1 Global Sepsis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Sepsis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Sepsis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sepsis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Sepsis Therapeutics Market Concentration Ratio
3.4.1 Global Sepsis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Therapeutics Revenue in 2023
3.5 Global Key Players of Sepsis Therapeutics Head office and Area Served
3.6 Global Key Players of Sepsis Therapeutics, Product and Application
3.7 Global Key Players of Sepsis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Therapeutics Breakdown Data by Type
4.1 Global Sepsis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Sepsis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Sepsis Therapeutics Breakdown Data by Application
5.1 Global Sepsis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Sepsis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sepsis Therapeutics Market Size (2019-2030)
6.2 North America Sepsis Therapeutics Market Size by Type
6.2.1 North America Sepsis Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Sepsis Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Sepsis Therapeutics Market Share by Type (2019-2030)
6.3 North America Sepsis Therapeutics Market Size by Application
6.3.1 North America Sepsis Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Sepsis Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Sepsis Therapeutics Market Share by Application (2019-2030)
6.4 North America Sepsis Therapeutics Market Size by Country
6.4.1 North America Sepsis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Sepsis Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Sepsis Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Sepsis Therapeutics Market Size (2019-2030)
7.2 Europe Sepsis Therapeutics Market Size by Type
7.2.1 Europe Sepsis Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Sepsis Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Sepsis Therapeutics Market Share by Type (2019-2030)
7.3 Europe Sepsis Therapeutics Market Size by Application
7.3.1 Europe Sepsis Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Sepsis Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Sepsis Therapeutics Market Share by Application (2019-2030)
7.4 Europe Sepsis Therapeutics Market Size by Country
7.4.1 Europe Sepsis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Sepsis Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Sepsis Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sepsis Therapeutics Market Size (2019-2030)
8.2 China Sepsis Therapeutics Market Size by Type
8.2.1 China Sepsis Therapeutics Market Size by Type (2019-2024)
8.2.2 China Sepsis Therapeutics Market Size by Type (2025-2030)
8.2.3 China Sepsis Therapeutics Market Share by Type (2019-2030)
8.3 China Sepsis Therapeutics Market Size by Application
8.3.1 China Sepsis Therapeutics Market Size by Application (2019-2024)
8.3.2 China Sepsis Therapeutics Market Size by Application (2025-2030)
8.3.3 China Sepsis Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Sepsis Therapeutics Market Size (2019-2030)
9.2 Asia Sepsis Therapeutics Market Size by Type
9.2.1 Asia Sepsis Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Sepsis Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Sepsis Therapeutics Market Share by Type (2019-2030)
9.3 Asia Sepsis Therapeutics Market Size by Application
9.3.1 Asia Sepsis Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Sepsis Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Sepsis Therapeutics Market Share by Application (2019-2030)
9.4 Asia Sepsis Therapeutics Market Size by Region
9.4.1 Asia Sepsis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Sepsis Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Sepsis Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Sepsis Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Sepsis Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Agennix
11.1.1 Agennix Company Details
11.1.2 Agennix Business Overview
11.1.3 Agennix Sepsis Therapeutics Introduction
11.1.4 Agennix Revenue in Sepsis Therapeutics Business (2019-2024)
11.1.5 Agennix Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Sepsis Therapeutics Introduction
11.2.4 AstraZeneca Revenue in Sepsis Therapeutics Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Atox Bio
11.3.1 Atox Bio Company Details
11.3.2 Atox Bio Business Overview
11.3.3 Atox Bio Sepsis Therapeutics Introduction
11.3.4 Atox Bio Revenue in Sepsis Therapeutics Business (2019-2024)
11.3.5 Atox Bio Recent Developments
11.4 CytoGenix
11.4.1 CytoGenix Company Details
11.4.2 CytoGenix Business Overview
11.4.3 CytoGenix Sepsis Therapeutics Introduction
11.4.4 CytoGenix Revenue in Sepsis Therapeutics Business (2019-2024)
11.4.5 CytoGenix Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Sepsis Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Sepsis Therapeutics Business (2019-2024)
11.5.5 Eli Lilly Recent Developments
11.6 Endacea
11.6.1 Endacea Company Details
11.6.2 Endacea Business Overview
11.6.3 Endacea Sepsis Therapeutics Introduction
11.6.4 Endacea Revenue in Sepsis Therapeutics Business (2019-2024)
11.6.5 Endacea Recent Developments
11.7 NexBio
11.7.1 NexBio Company Details
11.7.2 NexBio Business Overview
11.7.3 NexBio Sepsis Therapeutics Introduction
11.7.4 NexBio Revenue in Sepsis Therapeutics Business (2019-2024)
11.7.5 NexBio Recent Developments
11.8 Medinox
11.8.1 Medinox Company Details
11.8.2 Medinox Business Overview
11.8.3 Medinox Sepsis Therapeutics Introduction
11.8.4 Medinox Revenue in Sepsis Therapeutics Business (2019-2024)
11.8.5 Medinox Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Sepsis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Aminoglycosides Table 3. Key Players of Colony Stimulating Factors Table 4. Key Players of Second Generation Cephalosporins Table 5. Key Players of Third Generation Cephalosporins Table 6. Key Players of Glycopeptide Antibiotics Table 7. Key Players of Inhaled Intifectives Table 8. Key Players of Others Table 9. Global Sepsis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 10. Global Sepsis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 11. Global Sepsis Therapeutics Market Size by Region (2019-2024) & (US$ Million) Table 12. Global Sepsis Therapeutics Market Share by Region (2019-2024) Table 13. Global Sepsis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 14. Global Sepsis Therapeutics Market Share by Region (2025-2030) Table 15. Sepsis Therapeutics Market Trends Table 16. Sepsis Therapeutics Market Drivers Table 17. Sepsis Therapeutics Market Challenges Table 18. Sepsis Therapeutics Market Restraints Table 19. Global Sepsis Therapeutics Revenue by Players (2019-2024) & (US$ Million) Table 20. Global Sepsis Therapeutics Revenue Share by Players (2019-2024) Table 21. Global Top Sepsis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2023) Table 22. Global Sepsis Therapeutics Industry Ranking 2022 VS 2023 VS 2024 Table 23. Global 5 Largest Players Market Share by Sepsis Therapeutics Revenue (CR5 and HHI) & (2019-2024) Table 24. Global Key Players of Sepsis Therapeutics, Headquarters and Area Served Table 25. Global Key Players of Sepsis Therapeutics, Product and Application Table 26. Global Key Players of Sepsis Therapeutics, Product and Application Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 29. Global Sepsis Therapeutics Revenue Market Share by Type (2019-2024) Table 30. Global Sepsis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 31. Global Sepsis Therapeutics Revenue Market Share by Type (2025-2030) Table 32. Global Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 33. Global Sepsis Therapeutics Revenue Share by Application (2019-2024) Table 34. Global Sepsis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 35. Global Sepsis Therapeutics Revenue Share by Application (2025-2030) Table 36. North America Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 37. North America Sepsis Therapeutics Market Size by Type (2025-2030) & (US$ Million) Table 38. North America Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 39. North America Sepsis Therapeutics Market Size by Application (2025-2030) & (US$ Million) Table 40. North America Sepsis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 41. North America Sepsis Therapeutics Market Size by Country (2019-2024) & (US$ Million) Table 42. North America Sepsis Therapeutics Market Size by Country (2025-2030) & (US$ Million) Table 43. Europe Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 44. Europe Sepsis Therapeutics Market Size by Type (2025-2030) & (US$ Million) Table 45. Europe Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 46. Europe Sepsis Therapeutics Market Size by Application (2025-2030) & (US$ Million) Table 47. Europe Sepsis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 48. Europe Sepsis Therapeutics Market Size by Country (2019-2024) & (US$ Million) Table 49. Europe Sepsis Therapeutics Market Size by Country (2025-2030) & (US$ Million) Table 50. China Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 51. China Sepsis Therapeutics Market Size by Type (2025-2030) & (US$ Million) Table 52. China Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 53. China Sepsis Therapeutics Market Size by Application (2025-2030) & (US$ Million) Table 54. Asia Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 55. Asia Sepsis Therapeutics Market Size by Type (2025-2030) & (US$ Million) Table 56. Asia Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 57. Asia Sepsis Therapeutics Market Size by Application (2025-2030) & (US$ Million) Table 58. Asia Sepsis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 59. Asia Sepsis Therapeutics Market Size by Region (2019-2024) & (US$ Million) Table 60. Asia Sepsis Therapeutics Market Size by Region (2025-2030) & (US$ Million) Table 61. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Type (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Type (2025-2030) & (US$ Million) Table 63. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Application (2019-2024) & (US$ Million) Table 64. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Application (2025-2030) & (US$ Million) Table 65. Middle East, Africa, and Latin America Sepsis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 66. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country (2019-2024) & (US$ Million) Table 67. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size by Country (2025-2030) & (US$ Million) Table 68. Agennix Company Details Table 69. Agennix Business Overview Table 70. Agennix Sepsis Therapeutics Product Table 71. Agennix Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 72. Agennix Recent Developments Table 73. AstraZeneca Company Details Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Sepsis Therapeutics Product Table 76. AstraZeneca Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 77. AstraZeneca Recent Developments Table 78. Atox Bio Company Details Table 79. Atox Bio Business Overview Table 80. Atox Bio Sepsis Therapeutics Product Table 81. Atox Bio Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 82. Atox Bio Recent Developments Table 83. CytoGenix Company Details Table 84. CytoGenix Business Overview Table 85. CytoGenix Sepsis Therapeutics Product Table 86. CytoGenix Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 87. CytoGenix Recent Developments Table 88. Eli Lilly Company Details Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Sepsis Therapeutics Product Table 91. Eli Lilly Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 92. Eli Lilly Recent Developments Table 93. Endacea Company Details Table 94. Endacea Business Overview Table 95. Endacea Sepsis Therapeutics Product Table 96. Endacea Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 97. Endacea Recent Developments Table 98. NexBio Company Details Table 99. NexBio Business Overview Table 100. NexBio Sepsis Therapeutics Product Table 101. NexBio Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 102. NexBio Recent Developments Table 103. Medinox Company Details Table 104. Medinox Business Overview Table 105. Medinox Sepsis Therapeutics Product Table 106. Medinox Revenue in Sepsis Therapeutics Business (2019-2024) & (US$ Million) Table 107. Medinox Recent Developments Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global Sepsis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Sepsis Therapeutics Market Share by Type: 2023 VS 2030 Figure 3. Aminoglycosides Features Figure 4. Colony Stimulating Factors Features Figure 5. Second Generation Cephalosporins Features Figure 6. Third Generation Cephalosporins Features Figure 7. Glycopeptide Antibiotics Features Figure 8. Inhaled Intifectives Features Figure 9. Others Features Figure 10. Global Sepsis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 11. Global Sepsis Therapeutics Market Share by Application: 2023 VS 2030 Figure 12. Hospitals Case Studies Figure 13. Clinics Case Studies Figure 14. Other Case Studies Figure 15. Sepsis Therapeutics Report Years Considered Figure 16. Global Sepsis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 17. Global Sepsis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 18. Global Sepsis Therapeutics Market Share by Region: 2023 VS 2030 Figure 19. Global Sepsis Therapeutics Market Share by Players in 2023 Figure 20. Global Top Sepsis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2023) Figure 21. The Top 10 and 5 Players Market Share by Sepsis Therapeutics Revenue in 2023 Figure 22. North America Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. North America Sepsis Therapeutics Market Share by Type (2019-2030) Figure 24. North America Sepsis Therapeutics Market Share by Application (2019-2030) Figure 25. North America Sepsis Therapeutics Market Share by Country (2019-2030) Figure 26. United States Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Canada Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. Europe Sepsis Therapeutics Market Size YoY (2019-2030) & (US$ Million) Figure 29. Europe Sepsis Therapeutics Market Share by Type (2019-2030) Figure 30. Europe Sepsis Therapeutics Market Share by Application (2019-2030) Figure 31. Europe Sepsis Therapeutics Market Share by Country (2019-2030) Figure 32. Germany Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. France Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. U.K. Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Italy Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. Russia Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. Nordic Countries Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 38. China Sepsis Therapeutics Market Size YoY (2019-2030) & (US$ Million) Figure 39. China Sepsis Therapeutics Market Share by Type (2019-2030) Figure 40. China Sepsis Therapeutics Market Share by Application (2019-2030) Figure 41. Asia Sepsis Therapeutics Market Size YoY (2019-2030) & (US$ Million) Figure 42. Asia Sepsis Therapeutics Market Share by Type (2019-2030) Figure 43. Asia Sepsis Therapeutics Market Share by Application (2019-2030) Figure 44. Asia Sepsis Therapeutics Market Share by Region (2019-2030) Figure 45. Japan Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. South Korea Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. China Taiwan Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. Southeast Asia Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 49. India Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Australia Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Middle East, Africa, and Latin America Sepsis Therapeutics Market Size YoY (2019-2030) & (US$ Million) Figure 52. Middle East, Africa, and Latin America Sepsis Therapeutics Market Share by Type (2019-2030) Figure 53. Middle East, Africa, and Latin America Sepsis Therapeutics Market Share by Application (2019-2030) Figure 54. Middle East, Africa, and Latin America Sepsis Therapeutics Market Share by Country (2019-2030) Figure 55. Brazil Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Mexico Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. Turkey Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Saudi Arabia Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 59. Israel Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 60. GCC Countries Sepsis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million) Figure 61. Agennix Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 62. AstraZeneca Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 63. Atox Bio Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 64. CytoGenix Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 65. Eli Lilly Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 66. Endacea Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 67. NexBio Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 68. Medinox Revenue Growth Rate in Sepsis Therapeutics Business (2019-2024) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed
以下、関連資料のご紹介
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)